DOW JONES22,150.09+513.31 2.37%
S&P 5002,611.35+69.88 2.75%
NASDAQ7,753.75+251.38 3.35%

Morgan Stanley Downgrades Unum Therapeutics to Equal-Weight

Morgan Stanley analyst Vikram Purohit downgrades Unum Therapeutics (NASDAQ:UMRX) from Overweight to Equal-Weight.

Benzinga · 03/03/2020 10:03

Morgan Stanley analyst Vikram Purohit downgrades Unum Therapeutics (NASDAQ:UMRX) from Overweight to Equal-Weight.